• Mitochondrial Disease Treatment Candidate KH176 Shows Potential, Study Finds
  • ‘Rare Impact Awards’ Dinner Marks Orphan Drug Act and NORD at 35
  • #ECRD2018 – EU Must Do More for Rare Disease Patients, Eurordis Leaders Say
  • Multiple Consultations, Tests and Misdiagnoses Mark Mitochondrial Patients ‘Odyssey,’ Survey Finds
  • FDA Grants NeuroVive’s KL1333 Orphan Drug Status for Treatment of Mitochondrial Diseases
  • #ECRD2018 – Patient Access and Collaboration Focus of Eurordis Meeting May 10-12
  • #AAN2018 – Mutation in USMG5 Gene Causes Leigh Syndrome, Study Shows
  • Some Antioxidants Show Benefits in Models of Mitochondrial Disease, Study Reports
  • NIH Agency Pioneers Collaborative Research into Rare Diseases
  • Genetics Foundation to Donate Adapted Bikes to Charlotte-Area Children with Genetic Conditions During Day of Caring
  • Gene Mutation Leads to Early Childhood Neurodegenerative Disorder, Researchers Find
  • Abnormal Protein Interaction Impairs Mitochondrial Function, May Lead to Neurodegenerative Disorders, Study Suggests